Personalized medicineHumansVancomycinChildFemaleMale
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patients.
Nadeen Hossam, Dalia Makhlouf, Ahmed Elzeiny, Akram Elzeiny, Sherif Kamal, Omneya Hassanien, Lobna Shalaby, Mohamed Nagy
Published: 202510.1080/17410541.2025.2565143
Abstract
BACKGROUND: Vancomycin is a widely used nephrotoxic drug in pediatric oncology. Our aim was to assess the initial vancomycin dosing protocols required for achieving the target therapeutic concentrations of vancomycin between 10 and 20 mcg/ml. METHODS…
Preview only. Read the full abstract at the source